BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28495451)

  • 1. Comparison of Image Quality and Diagnostic Performance of Cone-Beam CT during Drug-Eluting Embolic Transarterial Chemoembolization and Multidetector CT in the Detection of Hepatocellular Carcinoma.
    Lucatelli P; Argirò R; Ginanni Corradini S; Saba L; Cirelli C; Fanelli F; Ricci C; Levi Sandri GB; Catalano C; Bezzi M
    J Vasc Interv Radiol; 2017 Jul; 28(7):978-986. PubMed ID: 28495451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
    Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
    J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of fusion images of unenhanced and contrast-enhanced arterial phase cone-beam CT in the detection of viable hepatocellular carcinoma during transarterial chemoembolization.
    Kim EH; Oh JS; Chun HJ; Choi BG; Lee HG
    Diagn Interv Radiol; 2018 Sep; 24(5):262-267. PubMed ID: 30211679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracy of Split-Bolus Single-Phase Contrast-Enhanced Cone-Beam CT for the Detection of Liver Tumors before Transarterial Chemoembolization.
    Jonczyk M; Chapiro J; Collettini F; Geisel D; Schnapauff D; Streitparth F; Schmidt T; Hamm B; Gebauer B; Wieners G
    J Vasc Interv Radiol; 2017 Oct; 28(10):1378-1385. PubMed ID: 28747271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
    Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
    J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?
    Loffroy R; Lin M; Yenokyan G; Rao PP; Bhagat N; Noordhoek N; Radaelli A; Blijd J; Liapi E; Geschwind JF
    Radiology; 2013 Feb; 266(2):636-48. PubMed ID: 23143027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
    Suk Oh J; Jong Chun H; Gil Choi B; Giu Lee H
    J Vasc Interv Radiol; 2013 Apr; 24(4):483-9. PubMed ID: 23452553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure.
    Lucatelli P; De Rubeis G; Ginnani Corradini L; Basilico F; Di Martino M; Lai Q; Ginanni Corradini S; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
    Eur J Radiol; 2020 Mar; 124():108806. PubMed ID: 31945673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.
    Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
    J Vasc Interv Radiol; 2013 Apr; 24(4):501-8. PubMed ID: 23452552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.
    Chen R; Geschwind JF; Wang Z; Tacher V; Lin M
    J Vasc Interv Radiol; 2013 Dec; 24(12):1837-44. PubMed ID: 24094672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Latest-generation Cone-beam Computed Tomography for Post Lipiodol-embolization Imaging in Hepatic Transarterial Chemoembolization in Comparison with Multi-detector Computed Tomography.
    Alizadeh LS; Koch V; Vogl TJ; Yel I; Gruenewald L; Albrecht MH; Herrmann E; von Knebel-Doeberitz PL; Booz C
    Acad Radiol; 2022 Jul; 29(7):e109-e118. PubMed ID: 34598867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography.
    Choi YR; Chung JW; Yu MH; Lee M; Kim JH
    PLoS One; 2018; 13(9):e0203940. PubMed ID: 30231076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-arm cone-beam CT parenchymal blood volume imaging for transarterial chemoembolization of hepatocellular carcinoma: implications for treatment planning and response.
    O'Donohoe RL; Kavanagh RG; Cahalane AM; Houlihan DD; McCann JW; Ryan ER
    Eur Radiol Exp; 2019 May; 3(1):21. PubMed ID: 31144237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cone Beam CT-Guided Chemoembolization of Probable Hepatocellular Carcinomas Smaller than 1 cm in Patients at High Risk of Hepatocellular Carcinoma.
    Choi JW; Kim HC; Lee JH; Yu SJ; Cho EJ; Kim MU; Hur S; Lee M; Jae HJ; Chung JW
    J Vasc Interv Radiol; 2017 Jun; 28(6):795-803.e1. PubMed ID: 28302348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Pung L; Ahmad M; Mueller K; Rosenberg J; Stave C; Hwang GL; Shah R; Kothary N
    J Vasc Interv Radiol; 2017 Mar; 28(3):334-341. PubMed ID: 28109724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma.
    Pritchard WF; Woods DL; Esparza-Trujillo JA; Starost MF; Mauda-Havakuk M; Mikhail AS; Bakhutashvili I; Leonard S; Jones EC; Krishnasamy V; Karanian JW; Wood BJ
    J Vasc Interv Radiol; 2020 May; 31(5):812-819.e1. PubMed ID: 32107125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Müller K; Datta S; Gehrisch S; Ahmad M; Mohammed MA; Rosenberg J; Hwang GL; Louie JD; Sze DY; Kothary N
    J Vasc Interv Radiol; 2017 Feb; 28(2):238-245. PubMed ID: 27914917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cone-Beam Computed Tomography-Hepatic Arteriography as a Diagnostic Tool for Small Hypervascular Hepatocellular Carcinomas: Method and Clinical Implications.
    Choi YR; Chung JW; Kim JH; Kim HC; Jae HJ; Hur S
    Korean J Radiol; 2020 Mar; 21(3):306-315. PubMed ID: 32090523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
    Yao X; Yan D; Jiang X; Li X; Zeng H; Liu D; Li H
    Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.